Great news indeed. To reduce side effects and so enable higher doses of Docetaxel is a major therapeutic benefit. This reminds me of the advance Don Metcalf brought by discovering CSF in the threatment of leukaemia. Unfortunately Australia lost the patent for this discovery and the benefits went to USA . This time Starpharma and Australia will benefit!
Great news indeed. To reduce side effects and so enable higher...
Add SPL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
9.8¢ |
Change
-0.002(2.00%) |
Mkt cap ! $40.48M | |||
| Open | High | Low | Value | Volume |
| 10.0¢ | 10.0¢ | 9.7¢ | $37.67K | 384.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 100000 | 9.6¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 9.8¢ | 39723 | 3 |
View Market Depth
| Last trade - 12.35pm 03/10/2024 (20 minute delay) ? |
| SPL (ASX) Chart |